Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA
Clotblog with Dr Samuel Goldhaber
View all posts »Quantifying bleeding risk with HAS-BLED
Jul 29, 2011 09:30 EDT-
1Comments
-
Read later
With its practical method of calculation, the HAS-BLED scoring system enables us to quantify the likelihood of major bleeding in anticoagulated patients with atrial fibrillation and aids communication among clinicians and patients.
Do you use the HAS-BLED score? How useful is it for your practice?
See:
Lip GYH. Implications of the CHADS-VASc and HAS-BLED scores for thromboprophylaxis in atrial fibrillation. Am J Med 2011; 124:111-114. Available here.
Lip GYH, Frison L, Halperin JL, et al. Comparative validation of a novel risk Score for predicting bleeding risk in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 2011; 57:173-180. Available here.
Pisters R, Lane D, Nieuwlaat R et al. A novel user-friendly score (HAS-BLED) to assess 1-Year risk of major bleeding in patients with atrial fibrillation. The Euro Heart Survey. Chest 2010; 138:1093-1100. Available here.
New bleeding score, HAS-BLED, will help guide anticoagulation in AF
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
